Drug · DIN 02539764
TECVAYLI
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 20, 2023; first marketed October 20, 2023.
- Drug Identification Number (DIN)
- 02539764
- Company (DIN owner)
- Janssen Inc.Toronto, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Teclistamab L01FX24
- Class
- Human
- Record last updated
- September 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TECLISTAMAB | 153 MG | 1.7 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 26, 2023: NOC 31304New Drug Submission (NDS)
Other DINs named TECVAYLI
- DIN 02539756 · Marketed